Executive Summary

Feb 2019
PROSPECTS
Pioneering ketoprofen and naproxen

At the end of the review period, manufacturers were testing consumers’ willingness to try out new systemic analgesics varieties in Bosnia-Herzegovina. Most notably, there was the introduction of ketoprofen and naproxen varieties, which have carved out solid share at the end of the review period thanks to advertising support.

Focus on adult ketoprofen

Adult ketoprofen is the highest value growth category in analgesics in Bosnia-Herzegovina during 2018. During the review period, there were several launches in the category, but more importantly mounting promotional support aimed at introducing consumers to the novelty in OTC analgesics.

Ibuprofen growing in paediatric analgesics

In paediatric analgesics, there is a similar trend in systemic analgesics: ibuprofen is growing faster than acetaminophen. With paediatric patients, systemic analgesics are primarily used for treating the symptoms of a fever.

COMPETITIVE LANDSCAPE
Bayer Pharma leads analgesics

The manufacturer of the Aspirin brand range, Bayer Pharma doo, leads analgesics in Bosnia-Herzegovina, ahead of the duo focusing on regional brands, Alkaloid doo and PGT Healthcare. By building a brand range, Bayer Pharma managed to expand the appeal of its Aspirin brand, customising it to match the individual needs of consumers, while maintaining the association with the Aspirin name and heritage.

Ketoprofen is soaring

The single most successful new launch in analgesics during 2018 was Dolorex, manufactured by the domestic leader Bosnalijek Pharmaceuticals dd. It is the most recent addition to the novel and increasingly propulsive format of adult ketoprofen, which is receiving lots of attention from manufacturers and key influencers at the end of the review period as a more effective alternative to ibuprofen and diclofenac, which is typically available only as Rx.

Independents having a rough time

While Alkaloid is attempting to update the image of its Caffetin brand by expanding its appeal, the once leading brand in analgesics recorded a strong decline during 2018. It is not that Alkaloid was not doing its best to upgrade its operations, but the competition is getting increasingly fierce as big international players invest heavily in promotion and distribution, effectively squeezing Alkaloid and other independent players out of analgesics.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Analgesics in Bosnia-Herzegovina

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Bosnia and Herzegovina with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Bosnia and Herzegovina, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Bosnia and Herzegovina market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Bosnia and Herzegovina?
  • What are the major brands in Bosnia and Herzegovina?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.